Table 1.
Transcription Factor or coactivator |
Gain-of-function cardiac phenotype |
Loss-of-function cardiac phenotype |
References |
---|---|---|---|
PPARα | ⇑FAO, lipotoxicity, HF- induced CM, ⇓-tolerance to I/R |
Mild. Resistance to I/R, ⇓work capacity |
83-87, 192 |
PPARβ/δ | ⇑glucose utilization, resistance to I/R, ⇑glycogen content |
⇓FAO, lipotoxic CM, early lethality |
81, 89, 90 |
PPARγ | Lipotoxic CM | Cardiac hypertrophy | 91, 92 |
ERRα | ND | ⇓respiratory efficiency, ⇓PCr, TAC-induced CM |
154 |
ERRγ | ND | Perinatal lethality | 68, 69 |
TFAM | Protects from MI induced heart failure |
Spontaneous CM | 77-79 |
PGC-1α | ⇑mitochondrial proliferation, reversible CM |
Energy deficiency (⇓ATP, ⇓PCr), TAC-induced CM, ⇓work capacity |
16, 49, 52, 153, 157 |
PGC-1β | ND | Mild energy deficiency, Perinatal lethality and mitochondrial dysfunction when combined with PGC- 1α KO |
163-165 |